ARHGDIA and TAGLN2 have both previously been shown to repress AR transcriptional activity, and to have tumour-suppressive roles [44–47]; their downregulation has clear implications for PC development, and further supports oncogenic activity of miR-346, 361-3p and -197. Here, ARHGDIA is linked to pachyonychia congenita.